| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.5M | +743.4% |
| Cost of Revenue | $20.5M | — |
| Gross Profit | -$13.0M | -1549.1% |
| R&D Expense | $42.6M | -40.8% |
| SG&A Expense | $22.6M | -17.8% |
| Operating Income | -$85.9M | +18.6% |
| Net Income | -$77.6M | +0.5% |
| EPS (Basic) | -$0.48 | +5.9% |
| EPS (Diluted) | -$0.48 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.2M | -42.0% |
| Accounts Receivable | $2.0M | -59.8% |
| Inventory | $3.4M | — |
| Current Assets | $118.1M | -22.1% |
| Total Assets | $143.2M | -17.5% |
| Current Liabilities | $19.8M | -29.4% |
| Long-term Debt | $0 | -100.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$54.9M | +32.7% |
| Capital Expenditures | $5.8M | -59.2% |
| Investing Cash Flow | $15.1M | +112.8% |
| Financing Cash Flow | $25.7M | +729.8% |
| Free Cash Flow | -$60.7M | +36.7% |
| +5.9% |
| Total Liabilities |
| $39.9M |
| +9.0% |
| Stockholders' Equity | $103.4M | -24.5% |